Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma.

Wang R, Wang D, Bai X, Guo J, Xia S, Cheng Y, Gu Y, Wang Q, Nie J, Chen D, Liu W, Liang J
Cell Death Discov. 2023 Jul 7;9(1):231. doi: 10.1038/s41420-023-01526-7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.